Evaluation of minimal residual disease in multiple myeloma patients by fluorescent‐polymerase chain reaction: the prognostic impact of achieving molecular responsePilar Martínez‐Sánchez, Joaquín Martínez‐López, Laura Montejano et al.|British Journal of Haematology|2008Cited by 58
Richter transformation driven by Epstein–Barr virus reactivation during therapy‐related immunosuppression in chronic lymphocytic leukaemiaMaría J. García‐Barchino, José A. Martinez‐Climent, Ken H. Young et al.|The Journal of Pathology|2018Cited by 37
Clinical applicability and prognostic significance of molecular response assessed by fluorescent‐<scp>PCR</scp>of immunoglobulin genes in multiple myeloma. Results from a<scp>GEM</scp>/<scp>PETHEMA</scp>studyJoaquín Martínez‐López, Elena Fernández‐Redondo, Ramón García‐Sánz et al.|British Journal of Haematology|2013Cited by 29
Application of Self-Quenched JH Consensus Primers for Real-Time Quantitative PCR of IGH Gene to Minimal Residual Disease Evaluation in Multiple MyelomaJoaquín Martínez‐López, Juan José Lahuerta, Pilar Martínez‐Sánchez et al.|Journal of Molecular Diagnostics|2006Cited by 1
Under Scope of the Current Redefinition Process of Optimal Response in Multiple Myeloma: Assesment of Molecular Response by Fluorescent PCR of Ig Genes Has Similar Applicability and Prognosis Impact to Immunophenotypic Response. (A GEM/PETHEMA study),Elena Fernandez Redondo, Juan José Lahuerta, Joaquín Martínez‐López et al.|Blood|2011Cited by 1